Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-β

Hippocampus

Volumn 23, Issue 8, 2013, Pages 696-707

  Costello, Derek A ^a   Lynch, Marina A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

IFNAR1; Interictal; Long term potentiation; NR2B; Poly(I:C)

Indexed keywords

ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 1; BETA INTERFERON; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN FUNCTION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; IN VITRO STUDY; MALE; MICROGLIA; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; SYNAPTIC EFFICACY;

IFNAR1; INTERICTAL; LONG-TERM POTENTIATION; NR2B; POLY(I:C);

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INTERFERON INDUCERS; INTERFERON-BETA; MAGNESIUM; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE NET; NEUROGLIA; NEURONS; POLY I-C; RECEPTORS, INTERFERON; TOLL-LIKE RECEPTOR 3;

EID: 84880811222     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.22129     Document Type: Article

References (65)

1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.
2. Aronica E, Ravizza T, Zurolo E, Vezzani A. 2012. Astrocyte immune responses in epilepsy. Glia 60:1258-1268.
3. Balistreri CR, Colonna-Romano G, Lio D, Candore G, Caruso C. 2009. TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol 29:406-415.
4. Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T, Vezzani A. 2008. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 131(Part 12):3256-3265.
5. Beyer S, Raether G, Stadler K, Hoffrogge R, Scharf C, Rolfs A, Mix E, Strauss U. 2009. Interferon-beta modulates protein synthesis in the central nervous system. J Neuroimmunol 213(1-2):31-38.
6. Carpenter S, Wochal P, Dunne A, O'Neill LA. 2011. Toll-like receptor 3 (TLR3) signaling requires TLR4 Interactor with leucine-rich REPeats (TRIL). J Biol Chem 286:38795-38804.
7. Casillas-Espinosa PM, Powell KL, O'Brien TJ. 2012. Regulators of synaptic transmission: Roles in the pathogenesis and treatment of epilepsy. Epilepsia 53 (Suppl 9):41-58.
8. Coan EJ, Collingridge GL. 1985. Magnesium ions block an N-methyl-D-aspartate receptor-mediated component of synaptic transmission in rat hippocampus. Neurosci Lett 53:21-26.
9. Costello DA, Lyons A, Denieffe S, Browne TC, Cox FF, Lynch MA. 2011a. Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: A role for Toll-like receptor activation. J Biol Chem 286:34722-34732.
10. Costello DA, Watson MB, Cowley TR, Murphy N, Murphy Royal C, Garlanda C, Lynch MA. 2011b. Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice. J Neurosci 31:3871-3879.
11. Cowley TR, O'Sullivan J, Blau C, Deighan BF, Jones R, Kerskens C, Richardson JC, Virley D, Upton N, Lynch MA. 2012. Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP. Neurobiol Aging 33:162-175.
12. Cunningham C, Campion S, Teeling J, Felton L, Perry VH. 2007. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun 21:490-502.
13. Daffis S, Samuel MA, Suthar MS, Gale M, Jr., Diamond MS. 2008. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol 82:10349-10358.
14. Dafny N, Prieto-Gomez B, Dong WQ, Reyes-Vazquez C. 1996. Interferon modulates neuronal activity recorded from the hypothalamus, thalamus, hippocampus, amygdala and the somatosensory cortex. Brain Res 734(1-2):269-274.
15. Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RA, Oldstone MB. 2004. Does Toll-like receptor 3 play a biological role in virus infections? Virology 322:231-238.
16. Field R, Campion S, Warren C, Murray C, Cunningham C. 2010. Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav Immun 24:996-1007.
17. Frasca A, Aalbers M, Frigerio F, Fiordaliso F, Salio M, Gobbi M, Cagnotto A, Gardoni F, Battaglia GS, Hoogland G, et al. 2011. Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. Neurobiol Dis 43:507-515.
18. Galic MA, Riazi K, Henderson AK, Tsutsui S, Pittman QJ. 2009. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis 36:343-351.
19. Getts DR, Balcar VJ, Matsumoto I, Muller M, King NJ. 2008. Viruses and the immune system: Their roles in seizure cascade development. J Neurochem 104:1167-1176.
20. Guidotti LG, Chisari FV. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19:65-91.
21. Hadjilambreva G, Mix E, Rolfs A, Muller J, Strauss U. 2005. Neuromodulation by a cytokine: Interferon-beta differentially augments neocortical neuronal activity and excitability. J Neurophysiol 93:843-852.
22. Hanke ML, Kielian T. 2011. Toll-like receptors in health and disease in the brain: Mechanisms and therapeutic potential. Clin Sci (Lond) 121:367-387.
23. Hess G, Aizenman CD, Donoghue JP. 1996. Conditions for the induction of long-term potentiation in layer II/III horizontal connections of the rat motor cortex. J Neurophysiol 75:1765-1778.
24. Hwang SY, Hertzog PJ, Holland KA, Sumarsono SH, Tymms MJ, Hamilton JA, Whitty G, Bertoncello I, Kola I. 1995. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci USA 92:11284-11288.
25. Jabs R, Seifert G, Steinhauser C. 2008. Astrocytic function and its alteration in the epileptic brain. Epilepsia 49 (Suppl 2):3-12.
26. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175:4320-4330.
27. Jensen MS, Yaari Y. 1988. The relationship between interictal and ictal paroxysms in an in vitro model of focal hippocampal epilepsy. Ann Neurol 24:591-598.
28. Jourdain P, Bergersen LH, Bhaukaurally K, Bezzi P, Santello M, Domercq M, Matute C, Tonello F, Gundersen V, Volterra A. 2007. Glutamate exocytosis from astrocytes controls synaptic strength. Nat Neurosci 10:331-339.
29. Klein M, Obermaier B, Angele B, Pfister HW, Wagner H, Koedel U, Kirschning CJ. 2008. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J Infect Dis 198:1028-1036.
30. Lafon M, Megret F, Lafage M, Prehaud C. 2006. The innate immune facet of brain: Human neurons express TLR-3 and sense viral dsRNA. J Mol Neurosci 29:185-194.
31. Lehnardt S. 2010. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 58:253-263.
32. Lyons A, Downer EJ, Costello DA, Murphy N, Lynch MA. 2012. Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia. J Neuroinflammation 9:107.
33. Lyons A, Griffin RJ, Costelloe CE, Clarke RM, Lynch MA. 2007. IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro. J Neurochem 101:771-781.
34. Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, Rossetti C, Molteni M, Casalgrandi M, Manfredi AA, et al. 2010. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16:413-419.
35. Mathern GW, Pretorius JK, Leite JP, Kornblum HI, Mendoza D, Lozada A, Bertram EH III. 1998. Hippocampal AMPA and NMDA mRNA levels and subunit immunoreactivity in human temporal lobe epilepsy patients and a rodent model of chronic mesial limbic epilepsy. Epilepsy Res 32(1-2):154-171.
36. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T. 2002. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293:1364-1369.
37. Mazarati A, Maroso M, Iori V, Vezzani A, Carli M. 2011. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and receptor for advanced glycation end products. Exp Neurol 232:143-148.
38. Mody I, Lambert JD, Heinemann U. 1987. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 57:869-888.
39. Moynagh PN. 2005. TLR signalling and activation of IRFs: Revisiting old friends from the NF-kappaB pathway. Trends Immunol 26:469-476.
40. Muller M, Fontana A, Zbinden G, Gahwiler BH. 1993. Effects of interferons and hydrogen peroxide on CA3 pyramidal cells in rat hippocampal slice cultures. Brain Res 619(1-2):157-162.
41. Nolan Y, Maher FO, Martin DS, Clarke RM, Brady MT, Bolton AE, Mills KH, Lynch MA. 2005. Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J Biol Chem 280:9354-9362.
42. O'Connor JJ, Coogan AN. 1999. Actions of the pro-inflammatory cytokine IL-1 beta on central synaptic transmission. Exp Physiol 84:601-614.
43. O'Neill LA. 2008. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 226:10-18.
44. Okun E, Griffioen K, Barak B, Roberts NJ, Castro K, Pita MA, Cheng A, Mughal MR, Wan R, Ashery U, et al. 2010. Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc Natl Acad Sci USA 107:15625-15630.
45. Okun E, Griffioen KJ, Mattson MP. 2011. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 34:269-281.
46. Olson JK, Miller SD. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916-3924.
47. Pestka S. 2007. The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem 282:20047-20051.
48. Riazi K, Galic MA, Kuzmiski JB, Ho W, Sharkey KA, Pittman QJ. 2008. Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci USA 105:17151-17156.
49. Richard KL, Filali M, Prefontaine P, Rivest S. 2008. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci 28:5784-5793.
50. Roberts ZJ, Goutagny N, Perera PY, Kato H, Kumar H, Kawai T, Akira S, Savan R, van Echo D, Fitzgerald KA, et al. 2007. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J Exp Med 204:1559-1569.
51. Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, Schwartz M. 2007. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 9:1081-1088.
52. Scumpia PO, Kelly KM, Reeves WH, Stevens BR. 2005. Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia 52:153-162.
53. Sellner J, Trinka E. 2012. Seizures and epilepsy in herpes simplex virus encephalitis: Current concepts and future directions of pathogenesis and management. J Neurol 259:2019-2030.
54. Swann JB, Hayakawa Y, Zerafa N, Sheehan KC, Scott B, Schreiber RD, Hertzog P, Smyth MJ. 2007. Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J Immunol 178:7540-7549.
55. Sweeney CM, Lonergan R, Basdeo SA, Kinsella K, Dungan LS, Higgins SC, Kelly PJ, Costelloe L, Tubridy N, Mills KH and others. 2011. IL-27 mediates the response to IFN-beta therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav Immun 25:1170-1181.
56. Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, et al. 2007. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci USA 104:13798-13803.
57. Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T. 2011. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25:1281-1289.
58. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, et al. 2003. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692-8700.
59. Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, Bode B, Manietta N, Walter J, Schulz-Schuffer W, et al. 2007. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol Biochem 20:947-956.
60. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366-1373.
61. Watson MB, Costello DA, Carney DG, McQuillan K, Lynch MA. 2010. SIGIRR modulates the inflammatory response in the brain. Brain Behav Immun 24:985-995.
62. Wyneken U, Marengo JJ, Villanueva S, Soto D, Sandoval R, Gundelfinger ED, Orrego F. 2003. Epilepsy-induced changes in signaling systems of human and rat postsynaptic densities. Epilepsia 44:243-246.
63. Xiong ZQ, Stringer JL. 2001. Prolonged bursts occur in normal calcium in hippocampal slices after raising excitability and blocking synaptic transmission. J Neurophysiol 86:2625-2628.
64. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-1527.
65. Zucker RS, Regehr WG. 2002. Short-term synaptic plasticity. Annu Rev Physiol 64:355-405.